PRDM6 and medulloblastoma: A minority of group 3/4 medulloblastoma tumours harbour single-gene oncogenic drivers, including MYC10 and MYCN11 amplifications as well as PRDM6 overexpression owing to enhancer hijacking by means of a tandem duplication of the adjacent SNCAIP gene2.